NAVANE Side Effects

7024335-1 | Tardive Dyskinesia
on May 17, 2010 Female patient from UNITED STATES , weighting 147.0 lb, was diagnosed with hallucination, psychotic disorder (What is psychotic disorder?) and was treated with Navane (View Usage). Patient experienced the following unwanted or unexpected effects: tardive dyskinesia. Navane dosage: 1 Mg. During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CELEXA (View Celexa Review and Celexa Label ).

7021348-0 | Mania, Thinking Abnormal
Patient was taking Navane (View Usage). Patient had the following side effects: mania, thinking abnormal on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 179.9 lb, was diagnosed with psychotic disorder (What is psychotic disorder?) and. Navane dosage: 1 Mg, 1x/day.

6933467-5 | Mania, Thinking Abnormal
Adverse event was reported on Aug 10, 2010 by a Male patient taking Navane (View Usage) (Dosage: 1 Mg, 1x/day) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: UNITED STATES , weighting 179.9 lb, After Navane was administered, patient had the following side effects: mania, thinking abnormal.

6916636-X | Bradyphrenia, Fatigue, Somnolence, Tachyphrenia
on Jan 16, 2009 Male patient from UNITED STATES , weighting 225.5 lb, was treated with Navane (View Usage). Patient experienced the following unwanted or unexpected effects: bradyphrenia, fatigue, somnolence, tachyphrenia. Navane dosage: 5 Mg, 2x/day. During the same period patient was treated with TOFRANIL (Unk) (View Tofranil Review and Tofranil Label ).


6912476-6 | Eructation, Flatulence, Middle Insomnia
on May 12, 2008 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with bipolar i disorder and was treated with Navane (View Usage). Patient had the following side effects: eructation, flatulence, middle insomnia. Navane dosage: . During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), TOFRANIL (View Tofranil Review and Tofranil Label ), AMBIEN (View Ambien Review and Ambien Label ).

6676137-3 | Anger, Anxiety, Dyspnoea, Fatigue, Goitre, Heart Rate Irregular, Irritability, Muscular Weakness, Prostatic Disorder
Patient was taking Navane (View Usage). After Navane was administered, patient had the following side effects: anger, anxiety (What is anxiety?), dyspnoea, fatigue, goitre, heart rate irregular, irritability, muscular weakness, prostatic disorder on Mar 31, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 163.0 lb, was diagnosed with psychotic disorder (What is psychotic disorder?), anxiety (What is anxiety?) and. Navane dosage: 4 Mg, 2x/day. During the same period patient was treated with KLONOPIN (0.25 Mg, Daily) (View Klonopin Review and Klonopin Label ).

6654538-7 | International Normalised Ratio Increased
Adverse event was reported on Mar 15, 2010 by a Male patient taking Navane (View Usage) (Dosage: 2 Mg, Daily) was diagnosed with schizophrenia, paranoid type and. Location: UNITED STATES , weighting 266.8 lb, Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. During the same period patient was treated with WARFARIN (7.5 Mg, Unk) (View Warfarin Review and Warfarin Label ), ABILIFY (30 Mg, Unk) (View Abilify Review and Abilify Label ), DOXAZOSIN (2 Mg, Unk) (View Doxazosin Review and Doxazosin Label ), GEMFIBROZIL (600 Mg, 2x/day) (View Gemfibrozil Review and Gemfibrozil Label ), LISINOPRIL (5 Mg, Daily) (View Lisinopril Review and Lisinopril Label ), METFORMIN (500 Mg, Daily) (View Metformin Review and Metformin Label ), NICOTINE (14 Mg, Unk) (View Nicotine Review and Nicotine Label ), LOVAZA (1 Mg, Daily) (View Lovaza Review and Lovaza Label ).

6451091-8 | Mania, Thinking Abnormal
on Nov 12, 2009 Male patient from UNITED STATES , weighting 185.0 lb, was diagnosed with psychotic disorder (What is psychotic disorder?) and was treated with Navane (View Usage). Patient had the following side effects: mania, thinking abnormal. Navane dosage: Unk.

5909271-3 | Asthenia, Body Height Decreased, Contusion, Disturbance In Attention, Dystonia, Immune System Disorder, Nasopharyngitis, Pain, Resorption Bone Increased
on Sep 25, 2008 Male patient from UNITED STATES , weighting 244.9 lb, was diagnosed with schizophrenia, skin exfoliation and was treated with Navane (View Usage). After Navane was administered, patient had the following side effects: asthenia, body height decreased, contusion, disturbance in attention, dystonia (What is dystonia?), immune system disorder, nasopharyngitis, pain (What is pain?), resorption bone increased. Navane dosage: .

5840945-9 | Movement Disorder
Patient was taking Navane (View Usage). Patient experienced the following unwanted or unexpected effects: movement disorder (What is movement disorder?) on Jul 30, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 210.5 lb, was diagnosed with schizophrenia and. Navane dosage: .

5839152-5 | Bipolar Disorder, Condition Aggravated
Adverse event was reported on Jul 29, 2008 by a Female patient taking Navane (View Usage) (Dosage: ) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , weighting 275.6 lb, Patient had the following side effects: bipolar disorder (What is bipolar disorder?), condition aggravated. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), COGENTIN (View Cogentin Review and Cogentin Label ), DEPAKOTE (View Depakote Review and Depakote Label ).

5620967-3 | Barrett's Oesophagus, Hepatic Enzyme Increased, Sinus Operation, Sinusitis
on Jan 29, 2008 Male patient from UNITED STATES , weighting 242.5 lb, was diagnosed with schizophrenia and was treated with Navane (View Usage). After Navane was administered, patient had the following side effects: barrett's oesophagus, hepatic enzyme increased, sinus operation, sinusitis (What is sinusitis?). Navane dosage: . During the same period patient was treated with PAMELOR (View Pamelor Review and Pamelor Label ).

5198901-2 | Adverse Event, Headache, Muscle Contractions Involuntary, Tachycardia, Weight Increased
on Aug 23, 2005 Female patient from UNITED STATES , weighting 125.0 lb, was diagnosed with ill-defined disorder and was treated with Navane (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, headache (What is headache?), muscle contractions involuntary, tachycardia, weight increased. Navane dosage: . During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ).

5193844-2 | Constipation, Dry Mouth, Heart Rate Increased, Hypertension, Somnolence
Patient was taking Navane (View Usage). Patient had the following side effects: constipation (What is constipation?), dry mouth, heart rate increased, hypertension, somnolence on Dec 08, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 160.0 lb, . Navane dosage: 15 Mg (5 Mg, 3 In 1 D) 4 Years Ago. During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ).

4957080-4 | Blood Cholesterol Increased, Blood Triglycerides Increased, Condition Aggravated, Depression, Incoherent, Trance
Adverse event was reported on Mar 10, 2006 by a Female patient taking Navane (View Usage) (Dosage: 2 Mg (2 Mg, Qd Interval: Every Day)) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , weighting 160.0 lb, After Navane was administered, patient had the following side effects: blood cholesterol increased, blood triglycerides increased, condition aggravated, depression (What is depression?), incoherent, trance. During the same period patient was treated with ANTIHISTAMINES (View Antihistamines Review and Antihistamines Label ). Patient was hospitalized and became disabled.

4892250-5 | Disease Recurrence
on Jan 25, 2006 Female patient from UNITED STATES , 47 years of age, weighting 212.0 lb, was diagnosed with schizophrenia and was treated with Navane (View Usage). Patient experienced the following unwanted or unexpected effects: disease recurrence. Navane dosage: 10 Mg Bid Po. Patient was hospitalized.

4847168-0 | Treatment Noncompliance, Vision Blurred, Weight Decreased
on Nov 21, 2005 Female patient from UNITED STATES , 50 years of age, weighting 180.0 lb, was diagnosed with anxiety (What is anxiety?), feeling of relaxation, thinking abnormal and was treated with Navane (View Usage). Patient had the following side effects: treatment noncompliance, vision blurred, weight decreased. Navane dosage: 4 Mg (4 Mg, 1 In 1 D), Oral.

4842317-2 | Diabetes Mellitus, Vision Blurred, Weight Decreased
Patient was taking Navane (View Usage). After Navane was administered, patient had the following side effects: diabetes mellitus, vision blurred, weight decreased on Nov 16, 2005 from UNITED STATES Additional patient health information: Female patient , 50 years of age, was diagnosed with anxiety (What is anxiety?) and. Navane dosage: 4 Mg (2 Mg, 1 In 1 D, Oral).

4704884-9 | Paranoia, Psychotic Disorder
Adverse event was reported on Feb 08, 2005 by a Male patient taking Navane (View Usage) (Dosage: ) . Location: , 38 years of age, weighting 275.0 lb, Patient experienced the following unwanted or unexpected effects: paranoia, psychotic disorder (What is psychotic disorder?).

4659965-5 | Accident, Body Height Decreased, Fatigue, Haemorrhage, Intervertebral Disc Protrusion, Malaise, Overdose, Overweight, Scar
on Apr 26, 2005 Male patient from , 56 years of age, was diagnosed with ill-defined disorder and was treated with Navane (View Usage). Patient had the following side effects: accident, body height decreased, fatigue, haemorrhage, intervertebral disc protrusion, malaise, overdose, overweight, scar (What is scar?). Navane dosage: 5 Mg Oral. During the same period patient was treated with PROCYCLIDINE HYDROCHLORIDE (PROCYCLIDINE HYDROCHLORIDE) (View Procyclidine Hydrochloride (procyclidine Hydrochloride) Review and Procyclidine Hydrochloride (procyclidine Hydrochloride) Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ). Patient was hospitalized.

4658608-4 | Accident, Fatigue, Growth Retardation, Haemorrhage, Insomnia, Intervertebral Disc Protrusion, Malaise, Overdose, Overweight
on Apr 26, 2005 Male patient from , 56 years of age, was diagnosed with ill-defined disorder and was treated with Navane (View Usage). After Navane was administered, patient had the following side effects: accident, fatigue, growth retardation, haemorrhage, insomnia, intervertebral disc protrusion, malaise, overdose, overweight. Navane dosage: 5 Mg, Oral. During the same period patient was treated with PROCYCLIDINE HYDROCHLORIDE (PROCYCLIDINE HYDROCHLORIDE) (View Procyclidine Hydrochloride (procyclidine Hydrochloride) Review and Procyclidine Hydrochloride (procyclidine Hydrochloride) Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ). Patient was hospitalized.

4556726-2 | Disease Recurrence, Feeling Abnormal, Hallucination, Loss Of Consciousness
Patient was taking Navane (View Usage). Patient experienced the following unwanted or unexpected effects: disease recurrence, feeling abnormal, hallucination, loss of consciousness on Jan 03, 2005 from Additional patient health information: Female patient , 30 years of age, was diagnosed with hallucination and. Navane dosage: Oral. During the same period patient was treated with GEODON (160 Mg (80 Mg, 2 In 1 D), Oral) (View Geodon Review and Geodon Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), QUETIAPINE FUMARATE (QUETIAPINE FUMARATE) (View Quetiapine Fumarate (quetiapine Fumarate) Review and Quetiapine Fumarate (quetiapine Fumarate) Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), TRAZODONE (TRAZODONE) (View Trazodone (trazodone) Review and Trazodone (trazodone) Label ).

4556627-X | Disease Recurrence, Feeling Abnormal, Hallucination, Loss Of Consciousness, Treatment Noncompliance
Adverse event was reported on Jan 05, 2005 by a Female patient taking Navane (View Usage) (Dosage: Oral) was diagnosed with hallucination and. Location: , 30 years of age, Patient had the following side effects: disease recurrence, feeling abnormal, hallucination, loss of consciousness, treatment noncompliance. During the same period patient was treated with GEODON (160 Mg (80 Mg, 2 In 1 D), Oral) (View Geodon Review and Geodon Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), QUETIAPINE FUMARATE (QUETIAPINE FUMARATE) (View Quetiapine Fumarate (quetiapine Fumarate) Review and Quetiapine Fumarate (quetiapine Fumarate) Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), TRAZODONE (TRAZODONE) (View Trazodone (trazodone) Review and Trazodone (trazodone) Label ).

4550052-3 | Agitation, Balance Disorder, Delusion, Dermatitis Contact, Diplopia, Dizziness, Dyspnoea, Ear Congestion
on Dec 28, 2004 Male patient from , weighting 244.0 lb, was diagnosed with delusion, hallucination, schizophrenia, paranoid type, psychotic disorder (What is psychotic disorder?), ill-defined disorder and was treated with Navane (View Usage). After Navane was administered, patient had the following side effects: agitation, balance disorder, delusion, dermatitis contact, diplopia, dizziness (What is dizziness?), dyspnoea, ear congestion. Navane dosage: 4 Mg (daily), Oral. During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), DIPHENHYDRAMINE (DIPHENHYDRAMINE) (View Diphenhydramine (diphenhydramine) Review and Diphenhydramine (diphenhydramine) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), HYDROXYZINE EMBONATE (HYDROXYZINE EMBONATE) (View Hydroxyzine Embonate (hydroxyzine Embonate) Review and Hydroxyzine Embonate (hydroxyzine Embonate) Label ).